These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Revealing the importance of carrier-cargo association in delivery of insulin and lipidated insulin. Diedrichsen RG; Harloff-Helleberg S; Werner U; Besenius M; Leberer E; Kristensen M; Nielsen HM J Control Release; 2021 Oct; 338():8-21. PubMed ID: 34298056 [TBL] [Abstract][Full Text] [Related]
4. Exploration of the Key Factors for Optimizing the in Vivo Oral Delivery of Insulin by Using a Noncovalent Strategy with Cell-Penetrating Peptides. Kamei N; Shigei C; Hasegawa R; Takeda-Morishita M Biol Pharm Bull; 2018; 41(2):239-246. PubMed ID: 29386483 [TBL] [Abstract][Full Text] [Related]
5. Increased Carrier Peptide Stability through pH Adjustment Improves Insulin and PTH(1-34) Delivery In Vitro and In Vivo Rather than by Enforced Carrier Peptide-Cargo Complexation. Kristensen M; Guldsmed Diedrichsen R; Vetri V; Foderà V; Mørck Nielsen H Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33092079 [TBL] [Abstract][Full Text] [Related]
6. Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium. Kamei N; Aoyama Y; Khafagy el-S; Henmi M; Takeda-Morishita M Eur J Pharm Biopharm; 2015 Aug; 94():42-51. PubMed ID: 25960330 [TBL] [Abstract][Full Text] [Related]
7. Penetratin-Mediated Transepithelial Insulin Permeation: Importance of Cationic Residues and pH for Complexation and Permeation. Kristensen M; Franzyk H; Klausen MT; Iversen A; Bahnsen JS; Skyggebjerg RB; Foderà V; Nielsen HM AAPS J; 2015 Sep; 17(5):1200-9. PubMed ID: 25990963 [TBL] [Abstract][Full Text] [Related]
8. One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats. Khafagy el-S; Kamei N; Nielsen EJ; Nishio R; Takeda-Morishita M Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):736-43. PubMed ID: 24060698 [TBL] [Abstract][Full Text] [Related]
9. Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport. Kamei N; Onuki Y; Takayama K; Takeda-Morishita M J Pharm Sci; 2013 Nov; 102(11):3998-4008. PubMed ID: 23963728 [TBL] [Abstract][Full Text] [Related]
10. Cellular Effects and Delivery Propensity of Penetratin Is Influenced by Conjugation to Parathyroid Hormone Fragment 1-34 in Synergy with pH. Kristensen M; Nielsen LH; Zor K; Boisen A; Christensen MV; Berthelsen J; Mørck Nielsen H Bioconjug Chem; 2018 Feb; 29(2):371-381. PubMed ID: 29155563 [TBL] [Abstract][Full Text] [Related]
11. Penetratin derivative-based nanocomplexes for enhanced intestinal insulin delivery. Zhu X; Shan W; Zhang P; Jin Y; Guan S; Fan T; Yang Y; Zhou Z; Huang Y Mol Pharm; 2014 Jan; 11(1):317-28. PubMed ID: 24255985 [TBL] [Abstract][Full Text] [Related]
12. Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane. Khafagy el-S; Iwamae R; Kamei N; Takeda-Morishita M AAPS J; 2015 Nov; 17(6):1427-37. PubMed ID: 26216471 [TBL] [Abstract][Full Text] [Related]
13. Cell-Penetrating Peptides as Carriers for Transepithelial Drug Delivery. Panou DA; Diedrichsen RG; Kristensen M; Nielsen HM Methods Mol Biol; 2022; 2383():371-384. PubMed ID: 34766302 [TBL] [Abstract][Full Text] [Related]
14. In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin. Nielsen EJ; Yoshida S; Kamei N; Iwamae R; Khafagy el-S; Olsen J; Rahbek UL; Pedersen BL; Takayama K; Takeda-Morishita M J Control Release; 2014 Sep; 189():19-24. PubMed ID: 24973720 [TBL] [Abstract][Full Text] [Related]
15. Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec). Zhu S; Chen S; Gao Y; Guo F; Li F; Xie B; Zhou J; Zhong H Drug Deliv; 2016 Jul; 23(6):1980-91. PubMed ID: 26181841 [TBL] [Abstract][Full Text] [Related]
16. Stereoisomer-Dependent Membrane Association and Capacity for Insulin Delivery Facilitated by Penetratin. Birch D; Sayers EJ; Christensen MV; Jones AT; Franzyk H; Nielsen HM Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376119 [TBL] [Abstract][Full Text] [Related]
17. Effects of intestinal luminal contents and the importance of microfold cells on the ability of cell-penetrating peptides to enhance epithelial permeation of insulin. Kamei N; Kawano S; Abe R; Hirano S; Ogino H; Tamiwa H; Takeda-Morishita M Eur J Pharm Biopharm; 2020 Oct; 155():77-87. PubMed ID: 32781024 [TBL] [Abstract][Full Text] [Related]
18. Stereochemistry as a determining factor for the effect of a cell-penetrating peptide on cellular viability and epithelial integrity. Birch D; Christensen MV; Staerk D; Franzyk H; Nielsen HM Biochem J; 2018 May; 475(10):1773-1788. PubMed ID: 29686042 [TBL] [Abstract][Full Text] [Related]
19. Conjugation of cell-penetrating peptides to parathyroid hormone affects its structure, potency, and transepithelial permeation. Kristensen M; de Groot AM; Berthelsen J; Franzyk H; Sijts A; Nielsen HM Bioconjug Chem; 2015 Mar; 26(3):477-88. PubMed ID: 25611217 [TBL] [Abstract][Full Text] [Related]
20. Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles. Alsulays BB; Anwer MK; Soliman GA; Alshehri SM; Khafagy ES Int J Nanomedicine; 2019; 14():9127-9138. PubMed ID: 31819423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]